Clinical Trial Update: Highdose Nicotine Patch Therapy for Smokeless Tobacco Use [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial assessed high-dose nicotine patch therapy to help reduce smokeless tobacco use, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smokeless Tobacco Use
• Tobacco Use Disorder

Drugs mentioned

• Nicotine patch (nicotine patch)

Snippet

Sponsor: Mayo Clinic | Conditions: Smokeless Tobacco Use | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-04-25